The CCT chaperonin is emerging as a key molecule linked to uncontrolled proliferation, invasion, migration, and tumorigenesis [21,22] and its subunits are reported to play a key role in many tumors, such as neuroblastoma [23], lung adenocarcinoma [24], hepatocellular carcinoma [25], colon rectal cancer [26], breast cancer [27], and GBM [16]. The gene discussed is FLVCR2; the disease is glioblastoma.